Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiological Effects of hERG Blockade on Metabolism
NCT03868657Phase 1Completed
- Start
- Jan 2019
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of moxifloxacin (2 arms). Primary endpoints: Serum Insulin and Glucagon-Like Peptide-1. Started Jan 2019; status: completed.
02
Drugs
moxifloxacin
Beyond the preview
Go deeper on NCT03868657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03868657.